Table of Content



1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions

2 BRIC Pharmaceuticals
2.1. Industry Outlook

3 Pharmaceuticals in Brazil
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
3.6. Macroeconomic Indicators

4 Pharmaceuticals in China
4.1. Market Overview
4.2. Market Data
4.3. Market Segmentation
4.4. Market outlook
4.5. Five forces analysis
4.6. Macroeconomic Indicators

5 Pharmaceuticals in India
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
5.6. Macroeconomic Indicators

6 Pharmaceuticals in Russia
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis

7 Company Profiles
7.1. Ache Laboratorios Farmaceuticos SA
7.2. Hypera SA
7.3. EMS Sigma Pharma
7.4. Yangtze River Pharmaceutical Group
7.5. Shanghai Pharmaceuticals Holding Co Ltd
7.6. Yunnan Baiyao Group Co Ltd
7.7. Guangzhou Pharmaceutical Holdings Ltd
7.8. Sun Pharmaceutical Industries Ltd
7.9. Lupin Ltd
7.10. Aurobindo Pharma Ltd
7.11. Dr. Reddy’s Laboratories Limited
7.12. Sanofi SA
7.13. Bayer AG
7.14. Les Laboratoires Servier
7.15. Novartis AG
7.16. Country data

8 Appendix
8.1. Methodology
8.2. About MarketLine



List of Figures

List of Figures
Figure 1: BRIC pharmaceuticals industry, revenue($bn), 2016-25
Figure 2: BRIC pharmaceuticals industry, revenue($bn), 2016-20
Figure 3: BRIC pharmaceuticals industry, revenue($bn), 2020-25
Figure 4: Brazil pharmaceuticals market value: $ billion, 2016-20
Figure 5: Brazil pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 6: Brazil pharmaceuticals market share: % share, by value, 2020
Figure 7: Brazil pharmaceuticals market value forecast: $ billion, 2020-25
Figure 8: Forces driving competition in the pharmaceuticals market in Brazil, 2020
Figure 9: Drivers of buyer power in the pharmaceuticals market in Brazil, 2020
Figure 10: Drivers of supplier power in the pharmaceuticals market in Brazil, 2020
Figure 11: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2020
Figure 12: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2020
Figure 13: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2020
Figure 14: China pharmaceuticals market value: $ billion, 2016-20
Figure 15: China pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 16: China pharmaceuticals market share: % share, by value, 2020
Figure 17: China pharmaceuticals market value forecast: $ billion, 2020-25
Figure 18: Forces driving competition in the pharmaceuticals market in China, 2020
Figure 19: Drivers of buyer power in the pharmaceuticals market in China, 2020
Figure 20: Drivers of supplier power in the pharmaceuticals market in China, 2020
Figure 21: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2020
Figure 22: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2020
Figure 23: Drivers of degree of rivalry in the pharmaceuticals market in China, 2020
Figure 24: India pharmaceuticals market value: $ billion, 2016-20
Figure 25: India pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 26: India pharmaceuticals market share: % share, by value, 2020
Figure 27: India pharmaceuticals market value forecast: $ billion, 2020-25
Figure 28: Forces driving competition in the pharmaceuticals market in India, 2020
Figure 29: Drivers of buyer power in the pharmaceuticals market in India, 2020
Figure 30: Drivers of supplier power in the pharmaceuticals market in India, 2020
Figure 31: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2020
Figure 32: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2020
Figure 33: Drivers of degree of rivalry in the pharmaceuticals market in India, 2020
Figure 34: Russia pharmaceuticals market value: $ billion, 2016-20
Figure 35: Russia pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 36: Russia pharmaceuticals market share: % share, by value, 2020
Figure 37: Russia pharmaceuticals market value forecast: $ billion, 2020-25
Figure 38: Forces driving competition in the pharmaceuticals market in Russia, 2020
Figure 39: Drivers of buyer power in the pharmaceuticals market in Russia, 2020
Figure 40: Drivers of supplier power in the pharmaceuticals market in Russia, 2020
Figure 41: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2020
Figure 42: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2020
Figure 43: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2020

List of Tables

List of Tables
Table 1: BRIC pharmaceuticals industry, revenue($bn), 2016-25
Table 2: BRIC pharmaceuticals industry, revenue($bn), 2016-20
Table 3: BRIC pharmaceuticals industry, revenue($bn), 2020-25
Table 4: Brazil pharmaceuticals market value: $ billion, 2016-20
Table 5: Brazil pharmaceuticals market geography segmentation: $ billion, 2020
Table 6: Brazil pharmaceuticals market share: % share, by value, 2020
Table 7: Brazil pharmaceuticals market value forecast: $ billion, 2020-25
Table 8: Brazil size of population (million), 2016-20
Table 9: Brazil gdp (constant 2005 prices, $ billion), 2016-20
Table 10: Brazil gdp (current prices, $ billion), 2016-20
Table 11: Brazil inflation, 2016-20
Table 12: Brazil consumer price index (absolute), 2016-20
Table 13: Brazil exchange rate, 2016-20
Table 14: China pharmaceuticals market value: $ billion, 2016-20
Table 15: China pharmaceuticals market geography segmentation: $ billion, 2020
Table 16: China pharmaceuticals market share: % share, by value, 2020
Table 17: China pharmaceuticals market value forecast: $ billion, 2020-25
Table 18: China size of population (million), 2016-20
Table 19: China gdp (constant 2005 prices, $ billion), 2016-20
Table 20: China gdp (current prices, $ billion), 2016-20
Table 21: China inflation, 2016-20
Table 22: China consumer price index (absolute), 2016-20
Table 23: China exchange rate, 2016-20
Table 24: India pharmaceuticals market value: $ billion, 2016-20
Table 25: India pharmaceuticals market geography segmentation: $ billion, 2020
Table 26: India pharmaceuticals market share: % share, by value, 2020
Table 27: India pharmaceuticals market value forecast: $ billion, 2020-25
Table 28: India size of population (million), 2016-20
Table 29: India gdp (constant 2005 prices, $ billion), 2016-20
Table 30: India gdp (current prices, $ billion), 2016-20
Table 31: India inflation, 2016-20
Table 32: India consumer price index (absolute), 2016-20
Table 33: India exchange rate, 2016-20
Table 34: Russia pharmaceuticals market value: $ billion, 2016-20
Table 35: Russia pharmaceuticals market geography segmentation: $ billion, 2020
Table 36: Russia pharmaceuticals market share: % share, by value, 2020
Table 37: Russia pharmaceuticals market value forecast: $ billion, 2020-25
Table 38: Ache Laboratorios Farmaceuticos SA: key facts
Table 39: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 40: Hypera SA: key facts
Table 41: Hypera SA: Annual Financial Ratios
Table 42: Hypera SA: Key Employees
Table 43: EMS Sigma Pharma: key facts
Table 44: EMS Sigma Pharma: Key Employees
Table 45: Yangtze River Pharmaceutical Group: key facts
Table 46: Yangtze River Pharmaceutical Group: Key Employees
Table 47: Shanghai Pharmaceuticals Holding Co Ltd: key facts
Table 48: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios
Table 49: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees
Table 50: Yunnan Baiyao Group Co Ltd: key facts
Table 51: Yunnan Baiyao Group Co Ltd: Annual Financial Ratios
Table 52: Yunnan Baiyao Group Co Ltd: Key Employees
Table 53: Guangzhou Pharmaceutical Holdings Ltd: key facts
Table 54: Guangzhou Pharmaceutical Holdings Ltd: Key Employees
Table 55: Sun Pharmaceutical Industries Ltd: key facts
Table 56: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 57: Sun Pharmaceutical Industries Ltd: Key Employees
Table 58: Sun Pharmaceutical Industries Ltd: Key Employees Continued
Table 59: Lupin Ltd: key facts
Table 60: Lupin Ltd: Annual Financial Ratios
Table 61: Lupin Ltd: Key Employees
Table 62: Lupin Ltd: Key Employees Continued
Table 63: Aurobindo Pharma Ltd: key facts
Table 64: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 65: Aurobindo Pharma Ltd: Key Employees
Table 66: Dr. Reddy’s Laboratories Limited: key facts
Table 67: Dr. Reddy’s Laboratories Limited: Annual Financial Ratios
Table 68: Dr. Reddy’s Laboratories Limited: Key Employees
Table 69: Sanofi SA: key facts
Table 70: Sanofi SA: Annual Financial Ratios
Table 71: Sanofi SA: Key Employees